Bristol-Myers Squibb intends to build a new large-scale multi-product bulk biologics manufacturing facility in Devens, MA, subject to final agreement between the company and the state. Construction is expected to begin by September 2006, and the facility is projected to be operationally complete in 2009. Commercial production of biologic compounds is anticipated to begin in 2011. Once operational, the site will require an initial workforce of approximately 350 employees. The facility will be des...